Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lennar A | LEN | Nov 25, 2024 | 178.66 | +5.61 |
Lennar B | LEN-B | Nov 25, 2024 | 168.26 | +4.84 |
Lennox International | LII | Nov 25, 2024 | 678.43 | +3.15 |
LENSAR | LNSR | Nov 25, 2024 | 7.36 | -0.27 |
LENZ Therapeutics | LENZ | Nov 25, 2024 | 35.88 | +1.07 |
Leonardo DRS | DRS | Nov 25, 2024 | 35.45 | -2.21 |
Lesaka Technologies | LSAK | Nov 25, 2024 | 5.25 | -0.19 |
Leslies | LESL | Nov 25, 2024 | 3.51 | +10.03 |
Levi Strauss & Co A | LEVI | Nov 25, 2024 | 17.11 | +4.84 |
Lexaria Bioscience | LEXX | Nov 25, 2024 | 2.15 | +2.87 |
Lexeo Therapeutics | LXEO | Nov 25, 2024 | 7.23 | +11.75 |
Lexicon Pharmaceuticals | LXRX | Nov 25, 2024 | 0.81 | -5.81 |
LexinFintech ADR | LX | Nov 25, 2024 | 3.40 | +0.30 |
LG Display ADR | LPL | Nov 25, 2024 | 3.48 | +0.87 |
LGI Homes | LGIH | Nov 25, 2024 | 111.22 | +5.10 |
LGL Group | LGL | Nov 25, 2024 | 6.00 | 0.00 |
Li Auto ADR | LI | Nov 25, 2024 | 22.44 | +0.72 |
Li Bang International | LBGJ | Nov 25, 2024 | 3.49 | 0.00 |
Li-Cycle | LICY | Nov 25, 2024 | 2.34 | +8.84 |
Liberty Allstar Equity Fund | USA | Nov 25, 2024 | 7.31 | +0.27 |
Liberty Allstar Growth Fund | ASG | Nov 25, 2024 | 5.85 | +1.04 |
Liberty Broadband A | LBRDA | Nov 25, 2024 | 85.02 | -1.47 |
Liberty Broadband A Pref | LBRDP | Nov 25, 2024 | 24.00 | +0.21 |
Liberty Broadband C | LBRDK | Nov 25, 2024 | 85.70 | -1.40 |
Liberty Global A | LBTYA | Nov 25, 2024 | 13.54 | +1.65 |
Liberty Global B | LBTYB | Nov 25, 2024 | 13.18 | 0.00 |
Liberty Global C | LBTYK | Nov 25, 2024 | 13.97 | +1.97 |
Liberty Global Class B | LBYAV | Nov 25, 2024 | 10.89 | 0.00 |
Liberty Latin America | LILA | Nov 25, 2024 | 7.48 | +5.20 |
Liberty Latin America | LILAK | Nov 25, 2024 | 7.42 | +5.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.